Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Anthera Pharmaceuticals Inc | 84 705 | déclaré | 05 janv. 2018 | tx 87+8 649 915−1 891 750 |
| Milestone Pharmaceuticals Inc. | 53 088 | déclaré | 31 mai 2022 | tx 12+130 780−76 780 |
| CymaBay Therapeutics, Inc. | 32 000 | déclaré | 26 janv. 2021 | tx 8+177 450 |
| Trius Therapeutics Inc | 0 | déclaré | 11 sept. 2013 | tx 15+61 364−84 037 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 31 mai 2022 | PURCHASE | Milestone Pharmaceuticals Inc. | 5 000 | 5.60 USD | 1er après silence |
| 31 mai 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 822 | 2.66 USD | |
| 31 mai 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 22 870 | 1.54 USD | |
| 31 mai 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 45 072 | 1.54 USD | |
| 31 mai 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 8 016 | 1.12 USD | |
| 31 mai 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 22 870 | 0.00 USD | deriv |
| 31 mai 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 8 016 | 0.00 USD | deriv |
| 31 mai 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 45 072 | 0.00 USD | deriv |
| 31 mai 2022 | EXERCISE | Milestone Pharmaceuticals Inc. | 822 | 0.00 USD | deriv |
| 14 juin 2021 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 30 000 | 0.00 USD | deriv |
| 26 janv. 2021 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 32 000 | 0.00 USD | deriv |
| 05 juin 2020 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 15 000 | 0.00 USD | deriv |
| 15 mai 2020 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 49 245 | 0.00 USD | deriv |
| 12 nov. 2019 | GRANT_AWARD | Milestone Pharmaceuticals Inc. | 4 000 | 0.00 USD | deriv |
| 29 janv. 2019 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 27 705 | 0.00 USD | deriv |
| 24 janv. 2018 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 16 000 | 0.00 USD | deriv |
| 05 janv. 2018 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 84 705 | 0.00 USD | deriv |
| 05 janv. 2018 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 84 705 | 0.00 USD | deriv |
| 22 sept. 2017 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 7 500 | 0.00 USD | deriv |
| 07 sept. 2017 | PURCHASE | Anthera Pharmaceuticals Inc | 5 000 | 1.34 USD | 1er après silence |
| 28 juin 2017 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 15 000 | 0.00 USD | deriv |
| 19 mai 2017 | OTHER | Anthera Pharmaceuticals Inc | 84 376 | 0.00 USD | deriv |
| 19 mai 2017 | OTHER | Anthera Pharmaceuticals Inc | 1 369 | 0.00 USD | deriv |
| 19 janv. 2017 | GRANT_AWARD | CymaBay Therapeutics, Inc. | 12 000 | 0.00 USD | deriv |
| 02 déc. 2016 | OTHER | Anthera Pharmaceuticals Inc | 180 000 | 0.00 USD | deriv |
2 achats déclarés après au moins 12 mois de silence — dernière occurrence le 31 mai 2022.